1963
DOI: 10.1021/jo01047a048
|View full text |Cite
|
Sign up to set email alerts
|

A New Approach to 16α-Hydroxycorticoids1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

1964
1964
2011
2011

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 3 publications
0
7
0
Order By: Relevance
“…Maintaining a similar, favorable acute‐toxicity profile, 79 is about two‐ to fourfold more potent than its parent 16 (Table 11). 261…”
Section: Lincosamidesmentioning
confidence: 99%
“…Maintaining a similar, favorable acute‐toxicity profile, 79 is about two‐ to fourfold more potent than its parent 16 (Table 11). 261…”
Section: Lincosamidesmentioning
confidence: 99%
“…The two drugs used in this study differ chemically in that the configuration of the lincomycin side chain has been altered in clindamycin by introduction of a chlorine atom on the 7-carbon (21). As a consequence of this, clindamycin is approximately 20 times more effective than lincomycin in inhibiting the growth of E. coli.…”
Section: Drug Binding Affinities Estimated By Footprintingmentioning
confidence: 99%
“…It can also be used to treat some protozoal diseases, such as malaria. Topical application of clindamycin phosphate is the treatment of mild to moderate acne and vaginosis [2]. Clindamycin dosage forms include capsules for peroral administration and injection solution containing clindamycin hydrochloride (I) (marketed under various trade names such as Dalacin-C and Clindacin) and a topical preparation of clindamycin phosphate (II) in solution form (known as Dalacin-T).…”
Section: Introductionmentioning
confidence: 99%